<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04558229</url>
  </required_header>
  <id_info>
    <org_study_id>MSD201959528</org_study_id>
    <nct_id>NCT04558229</nct_id>
  </id_info>
  <brief_title>RCT Evaluating Standardized Counseling on Early Discontinuation for Irregular Bleeding in Nexplanon Users</brief_title>
  <official_title>Randomized Control Trial Evaluating Impact of Standardized Counseling on Early Discontinuation for Irregular Bleeding in Users of the Contraceptive Implant</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Planned Parenthood of the St. Louis Region and Southwest Missouri</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Merck Sharp &amp; Dohme Corp.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Planned Parenthood of the St. Louis Region and Southwest Missouri</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Clinician counseling for implant users should involve an explanation of the likelihood of&#xD;
      irregular bleeding and the possibility of continued or frequent bleeding throughout three&#xD;
      years of use. If that counseling does not provide specifics of the actual distribution of&#xD;
      bleeding patterns described in published literature, there remains the real possibility of&#xD;
      biased or directed counseling, leading to an inaccurate and exaggerated expectation of&#xD;
      potential bleeding changes. This study aims to evaluate if a standardized script accompanied&#xD;
      by a visual aid regarding expected bleeding profiles, with intention to remove any&#xD;
      possibility of negative or positive framing, could change users' expectations and&#xD;
      satisfaction with their method, leading to lower discontinuation rates.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 24, 2020</start_date>
  <completion_date type="Anticipated">April 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2022</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>1:1 fashion with block sizes of 8 using a computer-generated random allocation</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
    <masking_description>All study team members will be blinded to the randomization, with the exception of the research member who will be delivering the counseling.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Nexplanon Discontinuation Rates</measure>
    <time_frame>6 months</time_frame>
    <description>Based subjects' self-reported ability to cope with various changes in bleeding patterns, and other demographic information, we will analyze whether an association exists between those who discontinue their method use early due to troublesome bleeding and the counseling they received on the day of method insertion.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">348</enrollment>
  <condition>Birth Control</condition>
  <condition>Contraception</condition>
  <condition>Contraceptive Usage</condition>
  <condition>Family Planning</condition>
  <arm_group>
    <arm_group_label>Standard of Care Clinician Counseling</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Additional Standardized Counseling</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Additional Standardized Counseling</intervention_name>
    <description>Research staff will follow a script designed to give unbiased, medically accurate information regarding bleeding changes that may occur with use of a contraceptive ENG implant.</description>
    <arm_group_label>Additional Standardized Counseling</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Presenting at the health center to receive an etonogestrel-releasing subdermal implant&#xD;
             (Nexplanon) for primarily contraceptive benefits&#xD;
&#xD;
          -  Ability to consent in English&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Have used an etonogestrel-releasing subdermal implant (Nexplanon) within the 12 weeks&#xD;
             prior to enrollment&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Cis-gendered females; Assigned female at birth and not using hormone therapy</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Colleen P McNicholas, DO, MSCI</last_name>
    <role>Principal Investigator</role>
    <affiliation>Planned Parenthood of the St. Louis Region and Southwest Missouri</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Loire Biggs</last_name>
    <phone>3145317526</phone>
    <phone_ext>384</phone_ext>
    <email>loire.biggs@ppslr.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tenaya Drapkin, MSW</last_name>
    <phone>3145317526</phone>
    <phone_ext>362</phone_ext>
    <email>tenaya.drapkin@ppslr.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Planned Parenthood of the St. Louis Region and Southwest Missouri</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63108</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Loire Biggs</last_name>
      <phone>314-531-7526</phone>
      <phone_ext>384</phone_ext>
      <email>loire.biggs@ppslr.org</email>
    </contact>
    <investigator>
      <last_name>Colleen P McNicholas, DO, MSCI</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>September 15, 2020</study_first_submitted>
  <study_first_submitted_qc>September 15, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 22, 2020</study_first_posted>
  <last_update_submitted>April 9, 2021</last_update_submitted>
  <last_update_submitted_qc>April 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Contraceptive implant</keyword>
  <keyword>Birth control</keyword>
  <keyword>Nexplanon</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

